--- title: "Innovative drug concept stocks are repeatedly active, HitGen and CHENGDA PHARMA both rise over 10%" type: "News" locale: "en" url: "https://longbridge.com/en/news/249491973.md" description: "HitGen and CHENGDA PHARMA both rose over 10%, while Baiotai, Sai Sheng Pharmaceutical, Livzon Pharmaceutical, Hitec Biopharma, Chenxin Pharmaceutical, and Jiankangyuan among others rose over 5%" datetime: "2025-07-22T01:52:14.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/249491973.md) - [en](https://longbridge.com/en/news/249491973.md) - [zh-HK](https://longbridge.com/zh-HK/news/249491973.md) --- # Innovative drug concept stocks are repeatedly active, HitGen and CHENGDA PHARMA both rise over 10% HitGen and CHENGDA PHARMA both rose over 10%, while Baiotai, Saiseng Pharmaceutical, Livzon Pharmaceutical Group, Hitec Biopharma, Chenxin Pharmaceutical, and Jiankangyuan among others rose over 5% ### Related Stocks - [688222.CN](https://longbridge.com/en/quote/688222.CN.md) - [301201.CN](https://longbridge.com/en/quote/301201.CN.md) ## Related News & Research - [14:47 ET6th Annual Midwest Design Awards Entry Period Now Open](https://longbridge.com/en/news/286808240.md) - [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md) - [](https://longbridge.com/en/news/286948461.md) - [09:15 ETNewport Healthcare's 2025 Outcomes Report Demonstrates Significant Improvements in Teen and Young Adult Mental Health Following Treatment](https://longbridge.com/en/news/286920260.md) - [00:45 ETAraceli Biosciences Launches Endeavor® Live Cell for Ultra-High-Throughput Kinetic Imaging in AI-Driven Drug Discovery](https://longbridge.com/en/news/287006505.md)